PreciseDx is Diagnostic Equipment in United States that focus on research experience business. Founded in 2019. They cover business area such as developer, artificial intelligence-guide pathology diagnostic, patient outcome, cancer, technology, diverse area, clinical modeling, patient phenotyping, image analysis, big datum, patient information, low-risk recurrence score, high accuracy, only hematoxylin, stain image, limited clinical datum.
2019
( 5 years old in 2024 )
Research Experience
-
1111 Amsterdam
Stuyvesant Building 8-808
New York, NY 10025
United States
Private
developerartificial intelligence-guide pathology diagnosticpatient outcomecancertechnologydiverse areaclinical modelingpatient phenotypingimage analysisbig datumpatient informationlow-risk recurrence scorehigh accuracyonly hematoxylinstain imagelimited clinical datum
* We use standard office opening hours in near PreciseDx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PreciseDx is Diagnostic Equipment business from United States that founded in 2019 (5 years old in 2024), PreciseDx business is focusing on Research Experience.
PreciseDx headquarter office and corporate office address is located in 1111 Amsterdam Stuyvesant Building 8-808 New York, NY 10025 United States.
PreciseDx was founded in United States.
In 2024, PreciseDx is currently focus on research experience sector.
Above is snippet of Google Trends for "research experience" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PreciseDx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
